HJ Research delivers in-depth insights on the global Infectious Disease Therapeutics market in its upcoming report titled, Global Infectious Disease Therapeutics Market Report 2018-2029. According to this study, the global Infectious Disease Therapeutics market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Infectious Disease Therapeutics market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Infectious Disease Therapeutics market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Infectious Disease Therapeutics industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Infectious Disease Therapeutics industry.
Global Infectious Disease Therapeutics market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Infectious Disease Therapeutics industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Infectious Disease Therapeutics market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Infectious Disease Therapeutics. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Infectious Disease Therapeutics market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Infectious Disease Therapeutics in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Infectious Disease Therapeutics market include:
Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH
Market segmentation, by product types:
Drugs
Vaccines
Market segmentation, by applications:
HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others
1 Industry Overview of Infectious Disease Therapeutics
1.1 Research Scope
1.2 Market Segmentation by Types of Infectious Disease Therapeutics
1.3 Market Segmentation by End Users of Infectious Disease Therapeutics
1.4 Market Dynamics Analysis of Infectious Disease Therapeutics
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Infectious Disease Therapeutics Industry
2.1 Novartis AG
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Gilead
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 GlaxoSmithKline plc
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Janssen Pharmaceutical Inc.
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 BioCryst Pharmaceuticals Inc.
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Merck & Co. Inc.
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Boehringer Ingelheim GmbH
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Infectious Disease Therapeutics Revenue and Gross Margin (2018-2023)
2.8.4 Contact Information
3 Global Infectious Disease Therapeutics Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Infectious Disease Therapeutics by Regions (2018-2023)
3.2 Global Sales Revenue of Infectious Disease Therapeutics by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Infectious Disease Therapeutics by Types (2018-2023)
3.4 Global Sales Revenue of Infectious Disease Therapeutics by End Users (2018-2023)
4 Northern America Infectious Disease Therapeutics Market Analysis by Countries, Types and End Users
4.1 Northern America Infectious Disease Therapeutics Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Infectious Disease Therapeutics Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Infectious Disease Therapeutics Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
4.5 Canada Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5 Europe Infectious Disease Therapeutics Market Analysis by Countries, Types and End Users
5.1 Europe Infectious Disease Therapeutics Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Infectious Disease Therapeutics Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Infectious Disease Therapeutics Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.5 France Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.6 UK Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.7 Italy Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.8 Russia Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.9 Spain Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
5.10 Netherlands Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6 Asia Pacific Infectious Disease Therapeutics Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Infectious Disease Therapeutics Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Infectious Disease Therapeutics Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Infectious Disease Therapeutics Sales Revenue Analysis by End Users (2018-2023)
6.4 China Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.5 Japan Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.6 Korea Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.7 India Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.8 Australia Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.9 Indonesia Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
6.10 Vietnam Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
7 Latin America Infectious Disease Therapeutics Market Analysis by Countries, Types and End Users
7.1 Latin America Infectious Disease Therapeutics Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Infectious Disease Therapeutics Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Infectious Disease Therapeutics Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
7.5 Mexico Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
7.6 Argentina Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
7.7 Colombia Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Infectious Disease Therapeutics Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Infectious Disease Therapeutics Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Infectious Disease Therapeutics Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Infectious Disease Therapeutics Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
8.6 South Africa Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
8.7 Egypt Infectious Disease Therapeutics Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Infectious Disease Therapeutics Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Infectious Disease Therapeutics by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Infectious Disease Therapeutics by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Infectious Disease Therapeutics by End Users (2024-2029)
10.4 Global Revenue Forecast of Infectious Disease Therapeutics by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Infectious Disease Therapeutics
11.1 Upstream Analysis of Infectious Disease Therapeutics
11.2 Downstream Major Consumers Analysis of Infectious Disease Therapeutics
11.3 Major Suppliers of Infectious Disease Therapeutics with Contact Information
11.4 Supply Chain Relationship Analysis of Infectious Disease Therapeutics
12 Infectious Disease Therapeutics New Project Investment Feasibility Analysis
12.1 Infectious Disease Therapeutics New Project SWOT Analysis
12.2 Infectious Disease Therapeutics New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Infectious Disease Therapeutics Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Infectious Disease Therapeutics
Table End Users of Infectious Disease Therapeutics
Figure Market Drivers Analysis of Infectious Disease Therapeutics
Figure Market Challenges Analysis of Infectious Disease Therapeutics
Figure Market Opportunities Analysis of Infectious Disease Therapeutics
Table Market Drivers Analysis of Infectious Disease Therapeutics
Table Novartis AG Information List
Figure Infectious Disease Therapeutics Specifications of Novartis AG
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of Novartis AG (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of Novartis AG (2018-2023)
Table Gilead Information List
Figure Infectious Disease Therapeutics Specifications of Gilead
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of Gilead (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of Gilead (2018-2023)
Table GlaxoSmithKline plc Information List
Figure Infectious Disease Therapeutics Specifications of GlaxoSmithKline plc
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of GlaxoSmithKline plc (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of GlaxoSmithKline plc (2018-2023)
Table Janssen Pharmaceutical Inc. Information List
Figure Infectious Disease Therapeutics Specifications of Janssen Pharmaceutical Inc.
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of Janssen Pharmaceutical Inc. (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of Janssen Pharmaceutical Inc. (2018-2023)
Table F. Hoffmann-La Roche Ltd. Information List
Figure Infectious Disease Therapeutics Specifications of F. Hoffmann-La Roche Ltd.
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of F. Hoffmann-La Roche Ltd. (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of F. Hoffmann-La Roche Ltd. (2018-2023)
Table BioCryst Pharmaceuticals Inc. Information List
Figure Infectious Disease Therapeutics Specifications of BioCryst Pharmaceuticals Inc.
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of BioCryst Pharmaceuticals Inc. (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of BioCryst Pharmaceuticals Inc. (2018-2023)
Table Merck & Co. Inc. Information List
Figure Infectious Disease Therapeutics Specifications of Merck & Co. Inc.
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of Merck & Co. Inc. (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of Merck & Co. Inc. (2018-2023)
Table Boehringer Ingelheim GmbH Information List
Figure Infectious Disease Therapeutics Specifications of Boehringer Ingelheim GmbH
Table Infectious Disease Therapeutics Revenue (Million USD) and Gross Margin of Boehringer Ingelheim GmbH (2018-2023)
Figure Infectious Disease Therapeutics Revenue (Million USD) and Global Market Share of Boehringer Ingelheim GmbH (2018-2023)
Table Global Revenue (Million USD) of Infectious Disease Therapeutics by Regions (2018-2023)
Table Global Revenue (Million USD) of Infectious Disease Therapeutics by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Infectious Disease Therapeutics by Types (2018-2023)
Table Global Revenue (Million USD) of Infectious Disease Therapeutics by End Users (2018-2023)
Table Northern America Infectious Disease Therapeutics Revenue (Million USD) by Countries (2018-2023)
Table Northern America Infectious Disease Therapeutics Revenue (Million USD) by Types (2018-2023)
Table Northern America Infectious Disease Therapeutics Revenue (Million USD) by End Users (2018-2023)
Figure United States Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Infectious Disease Therapeutics Revenue (Million USD) by Countries (2018-2023)
Table Europe Infectious Disease Therapeutics Revenue (Million USD) by Types (2018-2023)
Table Europe Infectious Disease Therapeutics Revenue (Million USD) by End Users (2018-2023)
Figure Germany Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Infectious Disease Therapeutics Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Infectious Disease Therapeutics Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Infectious Disease Therapeutics Revenue (Million USD) by End Users (2018-2023)
Figure China Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Infectious Disease Therapeutics Revenue (Million USD) by Countries (2018-2023)
Table Latin America Infectious Disease Therapeutics Revenue (Million USD) by Types (2018-2023)
Table Latin America Infectious Disease Therapeutics Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Infectious Disease Therapeutics Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Infectious Disease Therapeutics Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Infectious Disease Therapeutics Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Infectious Disease Therapeutics by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Infectious Disease Therapeutics by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Infectious Disease Therapeutics by End Users (2024-2029)
Table Major Consumers with Contact Information of Infectious Disease Therapeutics
Table Major Suppliers of Infectious Disease Therapeutics with Contact Information
Figure Supply Chain Relationship Analysis of Infectious Disease Therapeutics
Table New Project SWOT Analysis of Infectious Disease Therapeutics
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Infectious Disease Therapeutics
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Infectious Disease Therapeutics Industry
Table Part of References List of Infectious Disease Therapeutics Industry
Table Units of Measurement List
Table Part of Author Details List of Infectious Disease Therapeutics Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Infectious Disease Therapeutics industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Infectious Disease Therapeutics market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Infectious Disease Therapeutics manufacturers, Infectious Disease Therapeutics raw material suppliers, Infectious Disease Therapeutics distributors as well as buyers. The primary sources from the supply side include Infectious Disease Therapeutics manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Infectious Disease Therapeutics raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Infectious Disease Therapeutics industry landscape and trends, Infectious Disease Therapeutics market dynamics and key issues, Infectious Disease Therapeutics technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Infectious Disease Therapeutics competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Infectious Disease Therapeutics market size and forecast by regions, Infectious Disease Therapeutics market size and forecast by application, Infectious Disease Therapeutics market size and forecast by types, Infectious Disease Therapeutics company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
